Background: Little research addresses the actual status and future prospects of specialty training in Japan. The purpose of this research is to elucidate the actual status of Infectious Diseases (ID) Fellowship programs in Japan, their strong points and shortcomings, and to identify measures to improve them further from the viewpoints of both attending physicians and fellows.
Methods & Materials: We conducted qualitative interviews with an infectious diseases fellow and his/her attending physician from 10 institutions providing ID Fellowship in Japan, regarding the current status of the program. In addition, we also inquired about their views in regards to the ID fellowship policies implemented by the Japanese Association for Infectious Diseases (JAID). We qualitatively analyzed the data to delineate the actual status of each program and the fellowship program policies overall, and to identify measures for further improvement.
Results: The interviews revealed that there are largely two kinds of ID fellowships; American style ID programs entirely devoting full time to infectious diseases, and subordinate concepts of other subspecialties, such as pulmonary medicine, hematology, pediatrics, laboratory medicine or urology, where only a portion of hours were devoted to ID. Some institutions did not even have ID department. Time spent by the attending physicians for fellows also varied among programs, ranging from full time to the level of an advisor only if requested by the fellow. The needs for improvement also varied among interviewees; some being happy with the current system while others demanding radical reform.
Conclusion: Even though there are many ID fellowship programs in Japan, the content, the quality, and the concept of the programs apparently vary among programs. The perceptions by interviewees on the educational system differed, depending on the standpoints they have on ID physicians. There probably needs a coherency in the provision of ID fellowship programs so that fellows acquire competency in the subspecialty with sufficient expertise to act as independent ID specialists. Background: Autoimmune hepatitis (AIH) is a chronic autoimmune disease of the liver characterized by hyperglobulinemia, presence of autoantibodies and histological signs of chronic hepatitis in liver biopsy. There is no specific clinical sign or symptom. In 25-30% of the cases, it begins with acute symptoms and high transaminase values mimicking mostly an infectious process. We present a rare case of autoimmune hepatitis which became manifest by only the acute rise of fever.
Methods & Materials:
Thirty four year old female patient had the complaint of high fever for the last 10 days. There was no physical sign or symptom. CRP and sedimentation values were high and other results were; ALT 129 U/L, AST 78 U/L, Albumin 3.3 gr/dl, Globulin 3.7 gr/dl. Other biochemical, hematological test results and urine examination were all normal. Chest X ray, abdominal USG revealed no pathology. She had blood cultures which yielded no pathological growth of any bacteria and several serological tests for Toxoplasmosis, EBV, CMV, HBV, HCV, HAV, HIV, and Rubella which indicated past infections. She had a mild IgG2 positivity, together with ASMA: 1/80 (+) and LC-1 antibodies positivity in high titers. Liver biopsy revealed chronic hepatitis(interface hepatitis).
Results: She was diagnosed as AIH and immunosuppressive therapy with methylprednisolon 50 mg/day and azothiopurin 50 mg/day were started. Fever was under control after 48 hours of medication and 5 days later her CRP and other laboratory parameters returned to normal values. She is still under maintanance therapy.
Conclusion: Acute onset of AIH is a rare clinical manifestation of the chronic disease, and high fever being the initial and sole symptom is also rarely reported. Furthermore, Type 1 OIH is usually together with ANA and ASMA positivity, where as in type 2 OIH anti LKM 1 and anti LC-1 positivity are characteristic findings. Our case is considered as a rare case because of high fever being the initial symptom and both ASMA and anti LC-1 positivity were demonstrated. We highly recommend to look for AIH when investigating the etiology of high fever when there is no specific clinical data to indicate any infectious disease. Background: Malaria remains the most deadly parasitic disease to date, especially in sub-Saharan Africa, which comprises the majority of cases collected per year. It has long been accepted that four species of Plasmodium (P. falciparum, P. vivax, P. malariae and P. ovale) were responsible for the disease in humans. But quite recently, a fifth species, Plasmodium Knowlesi, has been identified as naturally infecting humans. Indeed, known for decades as naturally parasitizing the monkey Macaca fascicularis, P. knowlesi has long been confused, in terms of its evolutionary stage, with P. malariae or P. falciparum, which it resembles morphologically and it was not possible to properly differentiate them until the advent of molecular biology. To date, P. Knowlesi has only been identified in Southeast Asia and a similar phenomenon of natural transmission of simian plasmodium to humans has not been reported elsewhere. We therefore conducted this study to investigate the possible transmission of simian plasmodium to humans in populations living near the rainforest of the Democratic Republic of Congo (DRC) where several species of primates lives.
Methods & Materials: Three villages (Wenji-Secli, Bongonde, Bolenge) in the Province of Ecuador (North-eastern DRC) were selected because of their geographical location. Blood samples spotted on filter paper were collected from 100 people randomly taken in each village. Two successive RT-PCR were performed. A first one using a single probe able to diagnose all plasmodium spp and a second using four species-specific probes for the diagnosis of the four conventional human plasmodium species. Positivity in the first RT-PCR with negativity in the 2nd RT-PCR would suggest the presence of plasmodium species other than the four conventional.
Results: P. falciparum was correctly identified in 46.3% of samples. No other species of human plasmodium or not has been identified.
Conclusion: This preliminary study did not detect the presence of simian plasmodium in human populations living in the rainforest of the DRC. Studies with larger samples and with more advanced techniques should still be conducted. http://dx.doi.org/10. 1016/j.ijid.2014.03.741 
